Author

@Gantosj Gantosj

Named retail analyst championing a concentrated micro-cap lithium-DLE and biotech basket

Original bottom-up fundamental research and milestone tracki

trader score
+2.48
hit rate
70%
mean α
+1.10%
signals 14d
68

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 70% hit rate, +1.10% mean alpha, trader score +2.48. Their last-14d mentions, direction-adjusted, have moved -2.4% since posting (mean over 28 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-27CRDL@Gantosj+0.15Provides Phase 3 enrollment and topline-data timing for CRDL's recurrent pericarditis study.·
2026-08-27CNVI.V@Gantosj+0.55Scientific publication and clinical evidence support the company's hybrid IVUS/OCT imaging system.·
2026-08-27CNVIF@Gantosj+0.55Scientific publication and clinical evidence support the company's hybrid IVUS/OCT imaging system.·
2026-08-27CNVI.V@Gantosj+0.50Reports FDA 510(k) clearance for Conavi's next-generation hybrid IVUS-OCT imaging system.·
2026-08-27CNVIF@Gantosj+0.50Reports FDA 510(k) clearance for Conavi's next-generation hybrid IVUS-OCT imaging system.·
2026-08-27ASTS@Gantosj+0.60Reports BlueBirds 12 and 13 deployed, with 14 complete and 15–16 nearing completion ahead of launch.-5.5%
2026-08-26PNPNF@Gantosj+0.55Builds a conditional valuation thesis around an upcoming MRE and potential P/NAV re-rating.·
2026-08-26PNPN.V@Gantosj+0.55Builds a conditional valuation thesis around an upcoming MRE and potential P/NAV re-rating.·
2026-08-26VLTLF@Gantosj+0.35Identifies Packet Digital as the MOU customer sourcing domestic lithium for U.S. defense drone batteries.-1.5%
2026-08-26LIB.V@Gantosj+0.35Identifies Packet Digital as the MOU customer sourcing domestic lithium for U.S. defense drone batteries.·
2026-08-26LLY@Gantosj+0.10Argues Lilly's $3.2B Ventyx acquisition validates CRDL's field and could drive revaluation or a deal.-1.2%
2026-08-26CRDL@Gantosj+0.75Argues Lilly's $3.2B Ventyx acquisition validates CRDL's field and could drive revaluation or a deal.·
2026-08-26VTYX@Gantosj+0.50Argues Lilly's $3.2B Ventyx acquisition validates CRDL's field and could drive revaluation or a deal.·
2026-08-26EPRX@Gantosj+0.60Expects another leg higher after consolidation above a channel breakout and the 200DMA.-10.2%
2026-08-26CRDL@Gantosj+0.25Tracks CRDL's first test of $2.08 resistance and awaits a close above it to confirm breakout.·

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.